Sleep Disorders in Pregnancy: Unveiling Their Impact on Ischemic Placental Disease and Severe Morbidity

MedXY Editorial Team•Oct 9, 2025•Clinical Updates

Insomnia and obstructive sleep apnea (OSA) during pregnancy are linked to higher risks of ischemic placental disease (IPD), including preeclampsia, placental abruption, and small for gestational age (SGA) neonates.
Both sleep disorders significantly increase the risk of severe maternal morbidity (SM) and preterm birth compared with pregnancies unaffected by sleep disturbances.
Insomnia and OSA show distinct risk profiles, with insomnia associated with a notably higher risk of delivering SGA neonates.
Early recognition and targeted interventions for sleep disorders in pregnancy could potentially improve maternal and neonatal outcomes, although further research is needed on underlying mechanisms and treatment efficacy.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Insomnia and obstructive sleep apnea (OSA) during pregnancy are linked to higher risks of ischemic placental disease (IPD), including preeclampsia, placental abruption, and small for gestational age (SGA) neonates.
Both sleep disorders significantly increase the risk of severe maternal morbidity (SM) and preterm birth compared with pregnancies unaffected by sleep disturbances.
Insomnia and OSA show distinct risk profiles, with insomnia associated with a notably higher risk of delivering SGA neonates.
Early recognition and targeted interventions for sleep disorders in pregnancy could potentially improve maternal and neonatal outcomes, although further research is needed on underlying mechanisms and treatment efficacy.